Biologic approvals in 2008

Amgen (Thousand Oaks, California), Regeneron (Tarrytown, New York), ViroPharma (Exton, Pennsylvania) and ZymoGenetics (Seattle, Washington) all received US Food and Drug Administration (FDA) approvals last year for novel types of biologics (Table 1). For a full list of FDA approvals of drugs from public biotech companies, see Supplementary Table 1 online.

Table 1 Selected biologic approvals from public biotech companies in 2008^a